The global tally for the coronavirus-borne illness rose above 123 million on Monday, according to data aggregated by Johns Hopkins University, with the U.S. accounting for 24% of cases at 29.8 million. The global death toll grew to 2.71 million, with the U.S. toll of 542,359 accounting for 20.0%. There was positive news on the vaccine front in a study that found the vaccine developed by AstraZeneca PLC
and Oxford University was 79% effective and safe, showing no evidence of serious blood clotting that has been reported in a very small number of people in Europe and led to temporary halts of its use. The study conducted in the U.S. involved more than 32,000 people, AstraZeneca said Monday. The U.S. added at least 34,217 new cases on Sunday, according to a New York Times tracker, and at least 444 people died. Those numbers may be underreported given reduced staffing at hospitals on weekends.
The latest data from the Centers for Disease Control and Prevention shows that 156.7 million vaccine doses have been delivered and 124.4 million doses have been administered. There have been 81.4 million people, or 24.5% of the U.S. population, who have received at least one vaccine dose, while 44.1 million people, or 13.3% of the population, have been fully vaccinated.
Outside of the U.S., Brazil is second globally in cases at 11.9 million and also second with a death toll at 294,042. India is third worldwide in cases with 11.6 million and fourth in deaths at 159,967. Mexico is third by deaths at 198,036 and 13th highest by cases. The U.K. has 4.3 million cases and 126,393 deaths, the highest in Europe and fifth highest in the world.